Proathlete Wealth Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$789K Buy
5,404
+146
+3% +$21.3K 0.2% 36
2026
Q1
$760K Sell
5,258
-23
-0.4% -$3.49K 0.21% 35
2025
Q4
$757K Buy
5,281
+150
+3% +$22.1K 0.21% 36
2025
Q3
$788K Buy
5,131
+81
+2% +$12.7K 0.23% 33
2025
Q2
$808K Buy
5,050
+19
+0.4% +$3.1K 0.26% 32
2025
Q1
$861K Buy
5,031
+196
+4% +$32.8K 0.31% 34
2024
Q4
$811K Buy
4,835
+18
+0.4% +$3.07K 0.31% 35
2024
Q3
$835K Sell
4,817
-6
-0.1% -$1.02K 0.34% 33
2024
Q2
$795K Buy
4,823
+16
+0.3% +$2.62K 0.38% 30
2024
Q1
$780K Sell
4,807
-105
-2% -$16.5K 0.41% 29
2023
Q4
$720K Buy
+4,912
New +$728K 0.43% 25

Other funds holding PG

Proathlete Wealth Management's PG Position: Q2 2026 in Review

Proathlete Wealth Management increased its Procter & Gamble (PG) stake by 2.8% in Q2 2026, buying an estimated $21.3K and bringing the position to 5,404 shares worth $789K. The position accounts for 0.2% of the portfolio, ranked #36.

Proathlete Wealth Management first reported a position in PG in Q4 2023 and has held it in 11 quarters since. The position peaked at $861K in Q1 2025. 4,020 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Proathlete Wealth Management held 5,404 shares of Procter & Gamble worth $789K as of Q2 2026.
  • Proathlete Wealth Management bought 146 Procter & Gamble shares in Q2 2026, an estimated $21.3K.
  • Procter & Gamble made up 0.2% of Proathlete Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Proathlete Wealth Management first reported a position in Procter & Gamble in Q4 2023 and has held it in 11 quarters since.
  • Proathlete Wealth Management's Procter & Gamble position peaked at $861K in Q1 2025.
  • 4,020 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.